跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVIACT brivaracetam 50mg film-coated tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
BRIVIACT brivaracetam 50mg film-coated tablets blister pack
Approved
STANDARD
BRIVIACT brivaracetam 50mg film-coated tablets blister pack
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
282bfdc3fa19497c
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
282bfdc3fa19497c
Product Name
BRIVIACT brivaracetam 50mg film-coated tablets blister pack
Artg Id
243797
Artg Name
BRIVIACT brivaracetam 50mg film-coated tablets blister pack
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2016-08-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/aafd2775eb36f0267845ff28d155f7ff.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f0f8fe3e5656090a636ae7a51e5e6627.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
282bfdc3fa19497c
Type
Standard
Back to TGA Approvals
